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Abstract 21	
Scrapie infectivity enters the environment via a multiplicity of routes from infected animals. 22	
Environmentally associated scrapie persists on farms when infected animals have been removed 23	
and is particularly resistant to disinfection. Infectivity within the farm is not adequately removed by 24	
current recommended guidelines for farm decontamination. We describe an in vitro method for 25	
modelling decontamination, specifically the removal of scrapie prions from the surface of concrete 26	
fomites within buildings that have housed scrapie infected animals. Concrete that had been spiked 27	
with low amounts of a diluted scrapie positive brain homogenate was sampled before and after 28	
decontamination. Extracts were used to seed a semi-quantitative serial protein misfolding cyclic 29	
amplification assay (sPMCA). We demonstrate that methods currently recommended for prion 30	
decontamination result in inadequate reduction of prion seeding activity within this in vitro assay. 31	
Effective treatment was achieved using repeat dosing of surfaces with 20,000 ppm available 32	
chlorine for 4 hours. 33	
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Introduction 43	
Scrapie in sheep and goats is an example of a transmissible spongiform encephalopathy (TSE), a 44	
collection of fatal neurodegenerative diseases that affect a range of mammals including humans. 45	
The central event within all TSE’s, or ‘prion’ diseases, is the conversion of a benign cellular protein 46	
known as PrPC (the prion protein) into an alternate ‘misfolded’ conformational isomer commonly 47	
referred to as PrPSc. This disease associated form has the propensity to aggregate and form amyloid, 48	
and according to the prion hypothesis a misfolded conformer of this protein is proposed to comprise 49	
the infectious agent [1]. PrPC is ubiquitously expressed within different tissue types, though the 50	
misfolding events associated with disease are commonly associated with tissues of both the 51	
lympho-reticular system (LRS) and the central nervous system (CNS). Scrapie has been around for 52	
at least 200 years, more recently other TSEs have emerged such as bovine spongiform 53	
encephalopathy (BSE) in cattle and chronic wasting disease (CWD) in cervids.  A UK BSE 54	
epidemic peaking in the 1990s was due to recycling of bovine abattoir wastes within processed 55	
ruminant feeds. CWD was first observed in the 1960s and has spread to most states in the mid USA, 56	
and has recently been identified in Europe [2] its origin is unknown and it is highly infectious to 57	
cervid species and remains the only TSE that affects wild, free-ranging animals. Scrapie and CWD 58	
show many similarities in the tissue distribution of infectivity, and how infectivity is deposited in 59	
the environment via a number of secreted and excreted routes during preclinical and clinical stages 60	
of disease. For example, sheep infected with scrapie secrete/excrete prion within faeces [3], saliva 61	
[4,5], urine [6] and skin [7]. Furthermore, parturient material is known to harbor high levels of 62	
scrapie infectivity [8], and its presence correlates with an increase in the transmission of scrapie 63	
during the lambing season [9]. For scrapie and CWD, the dissemination of PrPSc coupled with its 64	
high stability leads to environmental reservoirs of infectivity [10].We have demonstrated that 65	
scrapie prions can be detected on a range of surfaces and dust within the farm providing likely 66	
sources of prion exposure [11,12]. Methods for effective scrapie decontamination have recently 67	
been reviewed [13], the recommended best practice for the decontamination of scrapie-affected 68	
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farm premises is to use a solution of 20,000ppm free chlorine as first described by Kimberlin et al 69	
[14] for the decontamination of rodent adapted prion, presented as that within infected brain 70	
homogenates. Under experimental conditions a pen disinfection consisting of thorough power 71	
washing followed by a 1 hour treatment with 20,000ppm free chlorine, had no effect on the kinetics 72	
of scrapie development in new born lambs that were introduced to that same pen when compared to 73	
a control pen that was not disinfected [15]. This suggests that the current disinfection process is 74	
ineffective against such environmentally associated infectivity. Here, we describe in vitro 75	
experiments involving protein misfolding cyclic amplification (PMCA) (16,17) that look to define 76	
how effective common disinfection regimes may be for the decontamination of surface bound 77	
prions, a situation that is likely to be found within farm buildings on both scrapie and CWD affected 78	
farms. 79	
Materials and methods 80	
Biological material: Scrapie free brain from animals of VRQ/VRQ PRNP genotype material was 81	
used to prepare the PMCA substrate, this was provided by the APHA and originated from the 82	
ARSU scrapie free sheep flock, a resource of TSE free sheep that was set up by the importation of 83	
scrapie-free sheep from New Zealand [18]. Scrapie brain material consisted of a pool of scrapie 84	
positive brainfrom scrapie infected sheep of VRQ/VRQ PRNP genotype and has previously been 85	
described [19]. Brain homogenates were prepared in deionized water containing 0.5% (w/v) sodium 86	
deoxycholate and 0.5% (v/v) Nonidet NP40; the use of detergent is a standard methodology to 87	
release cell associated PrPSc. The presence of detergents does not prevent PrPSc adsorption to 88	
fomites [19]. It is not known what form replicable prion is within the environment, i.e. cell 89	
associated or not and it is likely deposited from a multiplicity of routes in excreta/secreta. Here, our 90	
model uses detergent-treated brain material to represent prion not associated with cell membranes. 91	
Spiking bricks: To model scrapie decontamination of concrete surfaces, an important fomite within 92	
the built environment of the farm, 18x8 cm concrete bricks representing the type of surface material 93	
	5	
	
that would be on a commercial livestock barn floor were used. Bricks were spiked with dilutions of 94	
brain homogenate that would allow detection of amounts of prion that could be removed by 95	
swabbing the brick, and would allow a good assay dynamic range after decontamination. The 96	
amount to spike onto each brick was determined empirically using dilutions of brain at 5x10-5, 97	
5x10-6 and 5x10-7 dilutions of brain homogenate in PBS. 5 ml of each brain dilution was spread 98	
equally over the brick surface using a pipette and the bricks were allowed to air dry for 16 hours. 99	
After drying, each brick was washed 3x with sterile water (3x 500 mls). Pre decontamination swabs 100	
were then taken immediately after washing the bricks, whilst the bricks were still wet. When testing 101	
dilutions of spike to use, experiments were carried out in duplicate. When spiking bricks with 102	
dilutions of brain material for the decontamination experiments, experiments were carried out in 103	
triplicate. For the decontamination experiments all bricks were spiked with 5 ml of 1x10-5 dilution 104	
of scrapie brain homogenate. Control bricks were mock spiked with 5 ml of distilled water only. 105	
Decontamination of bricks: Bricks were decontaminated using the following treatment regimes: 1] 106	
unspiked control bricks had no decontamination treatment, spiked bricks were 2] painted with 2 107	
coats of thick floor paint, 3] 1 hour treatment with 20,000ppm free chlorine solution, 4] 1 hour 108	
treatment with 2M sodium hydroxide solution 5] 4 hour treatment with 20,000ppm free chlorine 109	
solution, with application of fresh solution every hour, 6] 1 hour treatment with 20,000ppm free 110	
chlorine solution, followed by 1 hour treatment with 2M sodium hydroxide. Free chlorine (from a 111	
solution of sodium hypochlorite) and hydroxide solutions were made up on the day of the 112	
experiment. The former taking into account the product decay curve data from the date of 113	
manufacture of the sodium hypochlorite solution. Solutions were added liberally to the bricks using 114	
a squeezy bottle and brick surfaces were not allowed to dry during the decontamination period. At 115	
the end of the treatment, bricks were washed with 5 applications of distilled water (5x 500 ml). Post 116	
decontamination swabs were then taken immediately after washing the bricks, whilst the bricks 117	
were still wet.      118	
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Swabbing of bricks: Before spiking with brain homogenate each brick was marked out with four 119	
2x10 cm areas using a marker pen. To swab each spiked brick before decontamination, 2 foam 120	
swabs (VWR) were used to sample 2 of the marked out areas. Briefly, a swab was wetted with 121	
sterile water and then passed over a 20 cm2 area, using 10 passes on each side of the swab. Swab 122	
samples were bagged and stored at -80 °C before extraction. Pre and post decontamination swabs 123	
were taken from different marked areas of the brick. 124	
Extraction of swabs: Extraction of swabs has been described previously [11]. Briefly, the foam 125	
heads from 2 swabs were incubated in a total volume of 6 ml extraction buffer (150 mM phosphate, 126	
0.5 % v/v NP40, 0.5 % v/v DOC, pH 7.0) for 2 hours with mixing. The swabs were removed from 127	
the buffer and PrPSc in the extraction solution was captured by addition of 80 µl of a 20 % w/v 128	
suspension of silicon dioxide (SiO2) in extraction buffer. The samples were incubated for 2 hours 129	
with agitation at room temperature. SiO2 was recovered by centrifugation at 800x g for 10 minutes 130	
and the supernatant removed. The pellet was washed with 1 ml of 0.1 % (w/v) SDS solution and 131	
then recovered by centrifugation at 420x g. Prion was eluted from the SiO2 by addition of 200 µl of 132	
a 1 % (w/v) SDS solution and vigorous vortexing for 3 minutes. The SiO2 was again pelleted by 133	
centrifugation at 420x g and the PrPSc containing supernatant was removed and stored at -20 °C 134	
until analysis. 135	
sPMCA: PrPSc levels within swab extracts were assayed by an ovine VRQ sPMCA. sPMCA was 136	
carried out as described previously [11]. Briefly a VRQ/VRQ 10% (w/v) brain homogenate was 137	
used as substrate and 10 µl of extract analysed in a 100 µl reaction volume. Amplifications were 138	
carried out 37 °C in a Misonix S4000 microplate horn set at 70 % power, with a 40 s sonication 139	
every 30 minutes. Reactions were diluted 1 in 3 every 24 hours with fresh VRQ/VRQ substrate and 140	
each amplification experiment was carried out for 9 days. In order to demonstrate that extracts 141	
contained no measurable matrix effects from residual sodium hypochlorite, 3 unspiked bricks 142	
treated with hypochlorite for 1 hour were swabbed and an extract for each was prepared, in addition 143	
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3 bricks that had not been spiked or decontaminated were also swabbed as a negative control 144	
extract. 10 µl of these extracts were added to PMCA reactions that had also been seeded with 10 µl 145	
of a 1x10-8 dilution of scrapie brain diluted into PMCA substrate and were amplified for 5 rounds of 146	
sPMCA. For the quantification of PrPSc sPMCA products, five separate PMCA replicates were 147	
carried out. 148	
Immunoblotting: sPMCA reaction products were digested with 50 µg/ml proteinase K (PK) for 1 149	
hour at 37°C and then resolved on a 12% NuPAGE Tris-Glycine SDS-PAGE gel (Invitrogen). 150	
Resolved proteins were transferred to a PVDF membrane by electroblotting, blocked with 3% w/v 151	
milk protein and then probed with the monoclonal antibody SHa31, followed by detection with an 152	
anti-mouse HRP conjugate (Dako). Blots were incubated with HRP substrate (Geneflow) and 153	
visualised using a Photek photon counting camera. sPMCA reactions were also analysed by a dot 154	
blot to determine the sPMCA round that the individual reactions became positive. Dot blots were 155	
carried out by spotting 1.8 µl of the PK digested reactions that had been boiled in LDS loading 156	
buffer, onto a nitrocellulose membrane. Blocking, probing and visualisation were carried out 157	
exactly as for western blots. Two samples that were representative of a strong positive and a weak 158	
positive western blot signal were routinely spotted in duplicates on each dot blot as internal controls 159	
to demonstrate the efficacy of the blots. These two dot blotting methodologies reproducibly show 160	
similar levels of sensitivity (data not presented).  161	
qsPMCA methods: In order to derive quantitative data from the sPMCA reactions a standard curve 162	
was generated using methodology similar to that reported by Haley et al [20]. In our experiments 163	
dilutions of the 10% (w/v) scrapie positive brain homogenate were amplified as replicates of 9; this 164	
was carried out for brain material diluted from 10-7 (1 ng brain per reaction) to 10-12 (10 fg brain per 165	
reaction). Samples were amplified for 9 sPMCA rounds and the positivity of each reaction at each 166	
round was analysed by dot blotting. As samples amplifying at earlier rounds represent those 167	
containing more prion, each reaction was scored where each round of amplification was given an 168	
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amplification score (if dot blot positive) from 1 (reaction positive at round 9) to 7 (if reaction 169	
positive at round 3). The possible total scores for a replicate of 9 could therefore range from 1 (1 170	
reaction only positive after 9 rounds) to 252 (if all 9 reactions were positive at round 3 through to 171	
round 9). From these scores a mean PMCA score (per reaction) was calculated for each brain 172	
dilution and this was plotted against the amount of brain spiked into the reaction. Similarly, a mean 173	
score was created from the sPMCA results from each test sample (mean score of 5 individual 174	
sPMCA replicates per sample extract), the mean scores from the analysis of 3 separate extracts were 175	
interpolated from the standard curve to estimate the average amount of brain standard equivalents 176	
that were present in an extract. 177	
Results 178	
To derive a scrapie brain standard curve, dilutions of scrapie positive brain homogenate were used 179	
to seed PMCA which was then taken to 9 rounds of amplification. PK digested PMCA reaction 180	
product was dot blotted at each round and scored as positive or negative for PrPSc. Mean PMCA 181	
scores were calculated for each brain dilution amplified and were used to plot brain dilution against 182	
PMCA reaction score (figure 1A). This standard curve gave an assay range over which the amount 183	
of scrapie prion in samples could be calculated. 184	
The appropriate amount of brain material with which to spike bricks was determined empirically. 185	
Duplicate bricks spiked with 5 ml of a 5x10-5, 5x10-6 or 5x10-7 dilution of brain, bricks were dried, 186	
washed and swabbed and then PrPSc extracted from the swabs. From our PMCA standard curve data 187	
we expected to be able to detect a brain spike after 5 rounds of sPMCA. At 5 rounds of sPMCA the 188	
only spiked samples detectable were extracts from bricks spiked with the 5x10-5 dilution of brain, 189	
duplicate brick extracts were positive in both sPMCA duplicates. At the 5x10-6 dilution only one of 190	
the brick extracts was positive in a single replicate (figure 1B). This experiment suggested that to 191	
have a good dynamic range for the sPMCA against the standard curve, bricks should be spiked with 192	
5 ml of 1x10-5 dilution of scrapie brain homogenate. 193	
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The hypochlorite treatment of the bricks did not leave any residue that could interfere with the 194	
sPMCA methodology, 10-8 brain dilution amplifications in the presence of control or hypochlorite 195	
extracts both scored 12/15 reactions positive at round 5 sPMCA, whilst at round 4 the positivity was 196	
7/15 and 9/15 reactions positive respectively (data not presented). 197	
To investigate the effect of scrapie prion decontamination in vitro we carried out trials of different 198	
decontamination methods using reagents that have previously shown efficacy in destroying prion 199	
infectivity, namely 2M NaOH and 20,000ppm free chlorine. All extracts from control bricks that 200	
were set up within the same experiment and left unspiked did not seed sPMCA, demonstrating both 201	
the high specificity of the sPMCA, and lack of cross contamination of prions during the 202	
experiments. For every treatment, the amounts of scrapie prion seed that were detected on concrete 203	
surfaces before decontamination ranged between 0.5-0.034 ng, mean 0.14 ng scrapie brain 204	
equivalent, across 15 individual spiked bricks figures 1C and 1D. This amount of detectable prion 205	
was within the same order of magnitude as the mean seeding activity detectable from swabs taken 206	
from concrete surfaces within a scrapie affected barn (mean brain equivalent 0.03ng brain, data not 207	
presented), quantified against the same brain reference material described here. Painting the surface 208	
of the spiked brick was expected to have the greatest reduction on the detection of scrapie prion 209	
post treatment, but remarkably a single sPMCA replicate was positive at 9 rounds of sPMCA 210	
following analysis of the three extracts. 2M NaOH was the most ineffective treatment with 211	
significant (5.96%) scrapie seeding activity being present after decontamination. After a single 212	
treatment of 20,000ppm free chlorine 0.17% of scrapie prion was still detectable. Repeat treatments 213	
of hypochlorite over four hours reduced the amount of scrapie to the levels detectable with the 214	
painted surface. The treatment of bricks with hypochlorite and then NaOH showed no further 215	
reduction in scrapie prion that either of the single treatments in isolation see table 1. 216	
 217	
 218	
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Discussion 219	
We have previously demonstrated that it is possible to detect and monitor environmental scrapie 220	
biochemically using a technique known as serial Protein Misfolding Cyclic Amplification 221	
(sPMCA), allowing the monitoring of scrapie infectivity on farm premises [11]. We again used this 222	
assay to monitor the presence of ovine scrapie prions contaminating a concrete surface, a scenario 223	
that is very likely to exist within the farm setting where livestock buildings will have been 224	
contaminated with prion containing material from a multiplicity of different sources from infected 225	
animals. Within this study we looked at those treatments that could reasonably be used in the farm 226	
setting using reagents that have previously shown efficacy against prions or are in current use as 227	
best practice. Within these experiments, concrete bricks spiked with dilute ovine scrapie positive 228	
brain homogenate were treated and then washed before swabbing to sample any remaining prion 229	
containing material. PMCA was carried out on extracts from these swabs taken both before and 230	
after the decontamination treatments and the amounts of scrapie prion that were detected were 231	
quantified using a semi-quantitative PMCA procedure. 232	
This laboratory model was set up to mimic the contamination of livestock buildings with scrapie 233	
infectivity. The sPMCA assay was used to detect prion seeding activity as a surrogate for 234	
infectivity. True infectivity can only be measured using the ovine or caprine host, or by taking 235	
environmental extracts and assaying these through transgenic mice susceptible to scrapie. These 236	
experiments take long periods of time and are very costly. Environmentally associated scrapie 237	
infectivity is likely to be derived from a number of sources such as faeces, skin, saliva and 238	
parturient material, and it is unknown how the infectious conformer of PrPSc is presented in such 239	
matrices. Brain derived prion was used as a model for scrapie infectivity bound to an environmental 240	
fomite. Here we used prion derived from sheep scrapie brain homogenates, previously studies have 241	
used brain homogenate to model the decontamination of surgical steel in studies into the 242	
decontamination of CJD within the healthcare system [21], or the decontamination of soil bound 243	
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prions [22]. This scenario does not model the effects of various sample matrices which may present 244	
infectious scrapie within the built environment. However in our experience surface bound scrapie 245	
prion seeding activity within such a farm situation can be devoid of gross debris such as faeces and 246	
bedding due to prior pressure washing of surfaces to remove all traces of gross contamination 247	
before chemical treatment. Here we investigated the decontamination of scrapie prions bound to a 248	
concrete support. Concrete surfaces are abundant within the commercial farm setting within barns 249	
and hard standings as a flooring and building material. The main constituents of concrete are 250	
aggregates made up of sand (silicon dioxide) and Portland cement whose composition is mainly 251	
made up of calcium silicates. Sand or silicon dioxide has previously been reported to bind prions 252	
[23], the close association of the prion protein with these components may be responsible for 253	
stabilising protein and increasing the resistance to chemical decontamination. The amounts of prion 254	
seeding activity that were recoverable from the spiked bricks was set at a level that was similar to 255	
mean levels of seeding activity that we had detected by taking surface swabs on an experimental 256	
sheep farm with a high incidence of scrapie. The experimental results should therefore model the 257	
relevant titres of prion within such an infected environment. The use of sPMCA to detect prions in 258	
extracts with reference to a standard curve allowed us to screen a range of disinfection regimes, in a 259	
cost effective and timely manner, a matter of days as opposed to months to years for mouse 260	
bioassay. Previous studies have demonstrated the effectiveness of methods to decontaminate prions 261	
from the surface of stainless steel, using rodent adapted prion contaminated wires and mouse 262	
bioassay [21], and have generally been carried out to determine methods for reducing prion 263	
infectivity on surgical equipment and instruments that may be reused within the healthcare system, 264	
where concern over contamination with vCJD is still of considerable concern. The methodology 265	
that we describe using a sPMCA based assay to test ovine scrapie prions could allow the high 266	
throughput screening of multiple disinfection reagents before moving on to transgenic mouse 267	
bioassay experiments to demonstrate effective removal of infectivity. Recently, and since the 268	
completion of this described study, at least two other reagents have been described with anti-prion 269	
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activities [24, 25]. These compounds, thiourea and hypochlorous acid are particularly interesting as 270	
they are reagents that are cheap to produce and can be used at the kind of scale required for farm-271	
scale decontamination at reasonable cost. These reagents would be suitable candidates to test using 272	
this PMCA based assay. 273	
This study demonstrates the inadequacy of scrapie removal using a 1 hour treatment with 20,000 274	
ppm free chlorine or with 2M sodium hypochlorite, reagents which are in use for the removal of 275	
prions from contaminated surfaces. We show that repeat dosing with 20,000 ppm free chlorine is 276	
more effective at inactivating prions than the single application for one hour, and in these 277	
experiments brought the levels of prion seeding activity down to that of the painted spiked bricks. 278	
We have previously demonstrated that on a scrapie affected farm the painting of a whole pen did 279	
not stop the transmission of scrapie to newborn lambs, although this slowed the infection kinetics 280	
compared to both hypochlorite treated and control (untreated) pens [15]. We have recently 281	
demonstrated that prion containing dusts are also present within such a farm environment [12]. It is 282	
likely that in addition to efficient removal of surface bound prions, any infectious material 283	
contained within farm dusts, which could quickly re-contaminate treated surfaces, will also need to 284	
be addressed. These extra measures need to be assessed within the farm environment, especially in 285	
the context of scrapie within goat farms where due to the poorly understood genetics surrounding 286	
scrapie resistance, no effective breeding strategy for scrapie resistance is available. Similar 287	
experimental methods as we describe here could be used specifically for the control of 288	
environmental CWD via effective decontamination of environmental fomites. 289	
Conclusion 290	
We used an in vitro model to assess reduction in scrapie seeding following chemical 291	
decontamination of surface bound prions.  Data indicates that current treatment methodology for the 292	
decontamination of farm buildings following outbreaks of scrapie (1 hour treatment with 20,000 293	
ppm free chlorine) are not effective in the inactivation of surface bound scrapie prions.  This same 294	
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chemical treatment is more effective however if applied as repeat applications of 20,000 ppm free 295	
chlorine every hour for 4 hours, this showed a similar level of prion reduction as painting over 296	
contaminated surfaces. 297	
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Figure legend: 372	
Figure 1: Determination of prion decontamination efficacy by distinct chemical treatment regimes. 373	
Prion levels were measured using a semi quantitative sPMCA method. A scrapie-affected brain 374	
standard curve is shown (A). Amplified dilutions of brain over the 9 rounds of sPMCA were dot 375	
blotted after PK-digestion and the total number of replicates used for each dilution scored taking 376	
into account the positivity at each round. The mean amplification score (total score divided by 377	
number of reactions) for each of the dilutions is plotted vs the amount of brain equivalent seed in 378	
ng. The recovery of PrPSc from concrete bricks was also assessed (B). Brain dilutions of 5x10-5, 379	
5x10-6, 5x10-7 or water (control), were spiked onto duplicate concrete bricks, washed, swabbed and 380	
any PrPSc extracted. Duplicate sPMCA reactions from two extracts were amplified for 5 rounds 381	
sPMCA before analysis of PK-resistance products on western blots. Bricks were spiked with 1x10-5 382	
dilution of scrapie brain homogenate or water (control). Molecular mass markers of 20 And 30 KDa 383	
are shown in B. Bricks were then decontaminated using the following treatment regimes: 1] control 384	
bricks had no decontamination treatment, spiked bricks were 2] painted with 2 coats of thick floor 385	
paint, 3] 1 hour treatment with 20,000ppm free chlorine solution, 4] 1 hour treatment with 2M 386	
sodium hydroxide solution 5] 4 hour treatment with 20,000ppm free chlorine solution, with 387	
application of fresh solution every hour, 6] 1 hour treatment with 20,000ppm free chlorine solution, 388	
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followed by 1 hour treatment with 2M sodium hydroxide. Swabs were taken before and after 389	
decontamination and prion present in extracts amplified as for the standard curve. Products were 390	
analysed by dot blot.  An example dot blot is shown (C), extracts from bricks decontaminated with 391	
4 hourly applications of 20,000ppm free chlorine. 1-5, 6-10, 11-15 are from 3 spiked bricks post 392	
treatment. 16-20, 21-25, 26-30 are pre-treatment. Dot blotting controls for a weak [C(W)] and 393	
strong [C(S)] scrapie signal on the dot blot are also analysed. For each decontamination regime, the 394	
ng brain equivalents, as determined by the semi quantitative sPMCA method by determining a 395	
mean score for each test sample and using the standard curve to estimate the average amount of 396	
brain standard equivalents that were present in an extract. For all blots, PrP was detected with 397	
monoclonal antibody SHa31. 398	
 399	
Table 1: sPMCA data on samples obtained from the contaminated bricks. The raw PMCA data 400	
scored from dot blots is recorded at each round (R3-R9), as pooled data for each of three replicates 401	
(5 replicates per sample). The PMCA total score is recorded for all replicates, and the mean score 402	
(total score divided by 15 replicates) is also shown. The mean score was used to determine the 403	
relative amount (in ng scrapie positive brain) per PMCA reaction, by reference to the standard 404	
curve. 405	
 406	
 407	
 408	
 409	
 410	
 411	
 412	
 413	
 414	
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Table 1 415	
 Number positive reactions (total 
triplicate analysis) at each round (R) 
Mean score 
(per reaction) 
Mean score 
Std Deviation 
(triplicate 
analyses)  
Prion 
amount 
(ng brain) 
Percentage 
seeding 
activity 
remaining  
Treatment Sampling R3  R4 R5 R6 R7 R8 R9 
Control Pre 0 0 0 0 0 0 0 0 0 0  
NA Post 0 0 0 0 0 0 0 0 0 0 
Painting Pre 9 15 15 15 15 15 15 25.1 2.4 0.53  
0.0006 Post 0 0 0 0 0 0 1 0.06 0.1 0.000003 
1 hour  2M 
NaOH 
Pre 0 4 15 15 15 15 15 16.6 2.7 0.064  
5.964 Post 0 1 1 1 2 2 8 2.3 2.0 0.0038 
1 hour 20,000 
ppm free 
chlorine 
Pre 0 2 3 10 15 15 15 12.46 2.2 0.035  
0.172 Post 0 0 0 0 0 1 1 0.27 0.4 0.00006 
4 hours 
20,000 ppm 
free chlorine 
Pre 0 5 15 15 15 15 15 17 1.8 0.066  
0.005 Post 0 0 0 0 0 0 1 0.06 0.1 0.000003 
1 hour 20,000 
ppm chlorine 
then 1 hour 
2M NaOH 
Pre 0 14 15 15 15 15 15 20.6 0.7 0.121  
0.275 Post 0 0 0 0 1 2 15 1.46 0.8 0.0003 
 416	
 417	
 418	
 419	
 420	
 421	
 422	
 423	
 424	
 425	
 426	
 427	
 428	
 429	
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